Peptides for Longevity
Peptides have moved from research labs and bodybuilding forums into mainstream conversation, and the pace of that shift has outrun both the evidence base and the regulation meant to sit around it. Patients are increasingly sourcing them online, often without any real understanding of what they're taking, why, or what's actually been studied.
This article breaks down what the evidence currently supports, where the major gaps remain, and what a properly monitored approach to peptide use looks like.
Peptides are short chains of amino acids that act as signalling molecules in the body, influencing everything from tissue repair to hormone release. Some, like insulin, have been used in medicine for decades. Others, now widely discussed online, sit in a far earlier and less certain stage of research.
The term "peptides" is often used as though it describes one category. It doesn't. It covers compounds with different mechanisms, different use cases, and, critically, very different levels of clinical evidence behind them.
Very few peptides in circulation have been through formal pharmaceutical development. GLP-1 agonists are the exception, having cleared the rigorous trial process required for regulatory approval. That distinction matters, it's the difference between a compound with real phase III data behind it and one whose use is extrapolated from far thinner evidence, sometimes nothing more than animal studies or anecdote.
Understanding this distinction is one of the more useful lenses for evaluating any claim made about a peptide, whether it's coming from a clinic, a supplement seller, or social media.
Grey market sourcing, buying peptides online without medical oversight, carries risks that go well beyond simply "it might not work".
- Purity and contamination, unregulated products carry no guarantee of what's actually in the vial
- Dosing errors, without clinical guidance, dosing is frequently self-estimated rather than calculated
- Blood-borne virus risk from unsterile injecting practices
- No monitoring, without bloodwork or follow-up, adverse effects can go undetected
A physician-supervised pathway addresses each of these directly: verified sourcing, physician-set dosing, and ongoing monitoring throughout use.
The regulatory picture around peptides is shifting, and it varies by jurisdiction and by compound. Broadly, regulators in Australia and the United States have been paying closer attention to how peptides are sourced, marketed and prescribed, and the rules in this space continue to evolve. Anyone considering peptide use should check the current position with a qualified prescriber rather than relying on marketing claims made online.
Peptide products are regulated as therapeutic goods, and regulators have been increasing scrutiny of how they're sourced and marketed online.
The regulatory position on compounded peptides has continued to evolve, with the rules differing depending on the specific compound.
A growing number of non-medical operators are running prescription-style services at scale, a model that carries risks most patients aren't aware of when they engage with it.
Beyond the current hype cycle, there's legitimate research interest in peptides for sarcopenia, bone health, cognitive decline, gut health, sleep and mood. The clinical case for these applications is still developing, but it's a meaningfully different conversation to the unregulated use currently circulating online.
The question isn't simply whether peptides work. It's whether anyone is monitoring what happens next. The difference between an informed, supervised patient and an uninformed one is the single biggest factor in whether peptide use is safe, effective, or neither.
Want to go deeper on this topic? Dr Adam Brown sat down with Tim Piatkowski, a leading researcher on image and performance enhancing drug use at the University of Queensland, for a full conversation covering the neuroscience of peptide-related mood changes, real-world sourcing patterns, and where this field is likely headed next.
Listen to the full episode on The Second Half →If you're considering peptide therapy as part of a longevity or preventive health plan, book a consultation with the team at the Longevity Medicine Institute.
